NASDAQ:AVTX

Avalo Therapeutics Stock Predictions

etoro logo Buy AVTX
*Your capital is at risk
$13.74
-0.220 (-1.58%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

AVTX Prediction Chart

AVTX Predictions History

Latest community submissions for AVTX.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 21, 2025 $16.57 -2.94% $17.43 X 95.09% 0
Oct 21, 2025 $16.76 -1.84% $17.43 X 96.16% 0
Oct 21, 2025 $17.12 +11.53% $17.43 V 98.22% 1
Sep 9, 2025 $11.06 -3.03% $11.61 X 95.30% 0
Sep 9, 2025 $11.19 -1.89% $11.61 X 96.42% 0
Sep 9, 2025 Bullish $11.61 V 1
Sep 9, 2025 Bullish $11.61 V 1
Feb 6, 2025 $8.04 -4.02% $8.19 V 98.21% 1
Feb 6, 2025 $8.17 -2.51% $8.19 V 99.75% 5
Feb 6, 2025 $34.46 +311.22% Unrealistic Excluded from avg $8.19 X 0.00% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for AVTX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT AVALO THERAPEUTICS, INC.
Avalo Therapeutics
Avalo Therapeutics, Inc., a clinical-stage precision medicine company, discovers, develops, and commercializes targeted therapeutics for patients with unmet clinical need in immunology, immuno-oncology, and rare genetic diseases. It develops AVTX-002, a fully human anti-LIGHT monoclonal antibody, which is under Phase II clinical trial for the treatment of non-eosinophilic asthma, as well as inflammatory bowel disease, including moderate to severe...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE